MarketWatch.com - Top Stories

Oil prices set to drop more as OPEC+ agrees to another ...

The largest group of oil-producing nations agreed over the weekend to sharply in...

As Congress returns, here’s where the Senate could make...

The Trump team and House leaders are pushing the Senate to aim for speed rather ...

Stock market’s haul in May comes as tariff turmoil and ...

S&P 500 seizes huge May gains — and lands back on the doorstep of record territory

Amid tariff agita, Wall Street is a bit more cautious t...

Earnings Watch: Dollar General, Dollar Tree, Victoria’s secret and other retaile...

My husband and I earn $115K. We’re inheriting $300K. Sh...

“We have $40,000 in credit-card debt and two financed vehicles with $100,000 in ...

Why the government’s debt problem is your borrowing pro...

People shopping for a car loan or a mortgage should understand the implications ...

Can media company spinoffs of brands like CNN and CNBC ...

Recent corporate media spinoffs have been a mixed bag, with many failing due to ...

‘I am getting very frustrated’: My mother’s adviser has...

“I am not used to this way of doing business.”

These 3 corporate tax breaks in the Republican megabill...

As a Republican-run Washington works to enact the party’s big tax and spending p...

Trump’s playbook may be tossed, but higher tariffs are ...

Is Trump’s trade strategy in limbo? Yes, but ‘Tariff Man’ has options.

Trump doubles steel tariffs to 50%, touts U.S. Steel-Ni...

The president said he is doubling duties on steel imports while talking up U.S. ...

S&P 500 scores best May since 1990, but stocks end mont...

U.S. stocks roared back in May as global trade tensions eased, but tariff-relate...

‘You are going to panic,’ Jamie Dimon tells regulators ...

The bond market is on edge, but less so this week after smooth Treasury auctions...

U.S.-China trade talks: Why rare-earth minerals are a s...

Component of cellphones and EVs is a thorn in negotiations.

Musk’s legacy at ‘DOGE’: A smaller Social Security Admi...

Busy signals, more required office visits and new procedures have led to fear an...

Regeneron dashes Wall Street’s hopes as COPD treatment ...

Regeneron’s stock is having its worst day in 14 years after the failure of late-...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.